SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-241119
Filing Date
2020-09-08
Accepted
2020-09-08 17:18:31
Documents
58
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d935225d10q.htm 10-Q 926596
2 EX-31.1 d935225dex311.htm EX-31.1 10583
3 EX-31.2 d935225dex312.htm EX-31.2 10494
4 EX-32.1 d935225dex321.htm EX-32.1 4929
  Complete submission text file 0001193125-20-241119.txt   4763364

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT annx-20200630.xml EX-101.INS 1122810
6 XBRL TAXONOMY EXTENSION SCHEMA annx-20200630.xsd EX-101.SCH 33219
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE annx-20200630_cal.xml EX-101.CAL 29786
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE annx-20200630_def.xml EX-101.DEF 161503
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE annx-20200630_lab.xml EX-101.LAB 294674
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE annx-20200630_pre.xml EX-101.PRE 242868
Mailing Address 180 KIMBALL WAY SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 180 KIMBALL WAY SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

IRS No.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39402 | Film No.: 201164880
SIC: 2834 Pharmaceutical Preparations